Anticonvulsant activity of azirino [1,2-d] [1,4]benzodiazepines and related 1,4-benzodiazepines in mice

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 1, 1997, Pages 281-289

  De Sarro, Giovambattista ^a,e   Chimirri, Alba ^b   McKernan, Ruth ^c   Quirk, Kathleen ^c   Giusti, Piero ^d   De Sarro, Angela ^a  

^a UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c Merck Sharp & Dohme Limited   (United Kingdom)

^d UNIVERSITY OF PADOVA   (Italy)

^e School of Medicine   (Italy)

Author keywords

Carbolines; 1,4 Benzodiazepines; Azirino l,2 d 1,4 benzodiazepines; Epilepsy; Flumazenil; Pentylenetetrazole; Rotarod and audiogenic seizures

Indexed keywords

4 ETHYL 6,7 DIMETHOXY BETA CARBOLINE 3 CARBOXYLIC ACID METHYL ESTER; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR; BETA CARBOLINE 3 CARBOXYLIC ACID METHYL ESTER; CAMAZEPAM; DIAZEPAM; FLUMAZENIL; FLUNITRAZEPAM; HALAZEPAM; OXAZEPAM; PENTETRAZOLE; PINAZEPAM; PRAZEPAM;

ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; AUDITORY STIMULATION; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; DRUG RECEPTOR BINDING; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANIMALS; ANTICONVULSANTS; BENZODIAZEPINES; CARBOLINES; CELL LINE; CONVULSANTS; FLUMAZENIL; GABA MODULATORS; MALE; MEMBRANES; MICE; MICE, INBRED DBA; MOVEMENT; PENTYLENETETRAZOLE; RADIOLIGAND ASSAY; RECEPTORS, GABA-A; SEIZURES;

ANIMALIA;

EID: 0030792653     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00565-5     Document Type: Article

References (50)

1. Allen M. S., Tan Y. C., Trudell L., Narayanan K., Schindler L. R., Martin M. J., Schultz C., Hagen T. J., Koehler K. F., Codding P. W., Skolnick P., Cook J. M. Synthetic and computer-assisted analyses of the pharmacophore for the benzodiazepine receptor inverse agonist site. J. Med. Chem. 33:1990;2343-2357.
2. 1 benzodiazepine receptor subclass. J. Neurochem. 37:1981;333-341.
3. Braestrup C., Nielsen M. Benzodiazepine receptor binding in vivo and efficacy. Olsen R. W., Venter J. C. Benzodiazepine/GABA receptor and chloride channels. Structural and functional properties:1986;167-184 Alan R. Liss, Inc, New York.
4. Braestrup C., Nielsen M., Honoré T., Jensen L. H., Petersen E. N. Benzodiazepine receptor ligands with positive and negative efficacy. Neuropharmacology. 22:1983;1451-1457.
5. Braestrup C., Schmiechen R., Neef G., Nielsen M., Petersen E. N. Interaction of convulsive ligands with benzodiazepine receptors. Science. 216:1982;1241-1243.
6. Brouillet E., Chaviox C., Bottlaender M., Khalili-Varasteh M., Hantraye P., Fournier D., Dodd R. H., Maziere M. In vivo bidirectional modulatory effect of benzodiazepine receptor ligands on GABAergic transmission evaluated by positron emission tomography in non-human primates. Brain Res. 557:1991;167-176.
7. +-conductance Brain Res. 271:1983;358-364.
8. Cassalotti S. A., Stephenson F. A., Barnard E. A. Separate subunits for agonist and benzodiazepine binding in the γ-aminobutyric acid receptor oligomer. J. Biol. Chem. 261:1986;15013-15016.
9. Chapman A. G., Croucher M. J., Meldrum B. S. Evaluation of anticonvulsant drugs in DBA/2 mice with sound-induced seizures. Arzneim. Forsch. 34:1984;1261-1264.
10. Chapman A. G., De Sarro G. B., Premachandra M., Meldrum B. S. Bidirectional effects of β-carbolines in reflex epilepsy. Brain Res. Bull. 19:1987;337-346.
11. Chapman A. G., Horton R. W., Meldrum B. S. Anticonvulsant action of a 1,5-benzodiazepine, clobazam, in reflex epilepsy. Epilepsia. 19:1978;293-299.
12. Chimirri A., Grasso S., Monforte A. M., Romeo G., Zappalá M. 3H-Azirino[1,2-d][1,4]benzodiazepin-4(5H)-ones. Synthesis and stereochemistry Heterocycles. 36:1993;691-699.
13. Costa E., Corda M. G., Guidotti A. On a brain polypeptide functioning as a putative effector for the recognition sites of benzodiazepine and beta-carboline derivatives. Neuropharmacology. 22:1983;1481-1492.
14. De Sarro G. B., Croucher M. J., Meldrum B. S. Anticonvulsant actions of DS 103-282. Pharmacological studies in rodents and the baboon Papio papio Neuropharmacology. 23:1984;526-530.
15. De Sarro G. B., Libri V., Ascioti C., Testa R., Nisticó G. Anticonvulsant effect of denzimol in DBA/2 mice. Neuropharmacology. 26:1987;1425-1429.
16. De Sarro G. B., Zappalá M., Grasso S., Chimirri A., De Sarro A. Molecular requirement for anticonvulsant activity in a series of thiazolo-1,4-benzodiazepines and comparison with classical benzodiazepines. Gen. Pharmacol. 24:1993;877-884.
17. De Sarro G. B., Zappalá M., Grasso S., Chimirri A., Spagnolo C., De Sarro A. Molecular requirement for anticonvulsant activity in a series of 1,5-benzodiazepine and [1,2,4]oxadiazolo[4,5-a][1,5]benzodiazepine derivatives. Mol. Neuropharmacol. 1:1992;195-202.
18. Diaz-Arauzo H., Koehler K. F., Hagen T. J., Cook J. M. Synthetic and computer assisted analysis of the pharmacophore for agonist at benzodiazepine receptors. Life Sci. 49:1991;207-216.
19. Doble A., Martin I. L. Multiple benzodiazepine receptors. No reason for anxiety Trends Pharmacol. Sci. 13:1992;76-81.
20. Duka T., Hoellt V., Herz A. In vivo receptor occupation by benzodiazepines and correlation with the pharmacological effect. Brain Res. 179:1979;147-156.
21. Dunham N. W., Miya T. S. A note on a simple apparatus for detecting neurological deficit in rats and mice. J. Am. Pharm. Assoc. 46:1957;208-209.
22. Gardner C. R. Functional in vivo correlates of the benzodiazepine agonist-inverse agonist continuum. Proc. Neurobiol. 31:1988;425-476.
23. Gardner C. R., Tully W. R., Hedgecock C. J. R. The rapidly expanding range of neuronal benzodiazepine receptor ligands. Prog. Neurobiol. 40:1993;1-61.
24. Gardner C. R., Ward R. A., Deacon R. M. J., Bagust J., Walker R. J. Effects of RU33368, a low affinity ligand for neuronal benzodiazepine receptors, on rodent behaviours and GABA-mediated synaptic transmission in rat cerebellar slices. Gen. Pharmacol. 23:1992;1193-1198.
25. Hadingham K. L., Harkness P. C., McKernan R. M., Quirk K., Le Bourdelles B., Horne A. L., Kemp J. A., Barnard E. A., Ragan C. I., Whiting P. J. Stable expression of mammalian type A γ-aminobutyric acid receptors in mouse cells. Demonstration of functional assembly of benzodiazepine-responsive site Proc. Natl. Acad. Sci. USA. 89:1992;6378-6382.
26. Harvey S. C. Hypnotics and sedatives. Gilman A. G., Goodman L. S., Rall T. W., Murod F. The pharmacological basis of therapeutics. 1985;339-371 MacMillan, New York.
27. Jensen L. H., Petersen E. N., Braestrup C. Audiogenic seizures in DBA/2 mice discriminate sensitively between low efficacy benzodiazepine receptor agonists and inverse agonists. Life Sci. 33:1983;393-399.
28. A receptors. Neuron. 3:1989;745-753.
29. Litchfield J. T., Wilcoxon F. A simplified method of evaluating dose-effects experiments. J. Pharmacol. Exp. Ther. 96:1949;99-111.
30. Martin Y. C. Quantitative drug design. Grunewald G. L. Medicinal research, vol. 8. 1978;377-393 Marcel Decker, New York.
31. McLean M. J., MacDonald R. L. Benzodiazepines, but not β-carbolines, limit high frequency repetitive firing of action potentials of spinal cord neurons in cell culture. J. Pharmacol. Exp. Ther. 224:1988;789-795.
32. McPherson G. I. Ligand. 1987;Elsevier Biosoft, release 2.0). Cambridge, UK.
33. Meldrum, B. S.; Braestrup, C.: GABA and the anticonvulsant action of benzodiazepines and related drugs. In: Bowery, N. G., ed. Actions and interactions of GABA and benzodiazepines. New York; Raven Press; 1984:133-153.
34. ++. Reversal by dihydropyridine calcium channel antagonists Eur. J. Pharmacol. 104:1984;181-183.
35. Mennini T., Garattini S. Benzodiazepine receptors. Correlation with pharmacological responses in living animals Life Sci. 31:1982;2025-2035.
36. Miller L. G., Greedblatt D. J., Paul S. M., Shader S. I. Benzodiazepine receptor occupancy in vivo. Correlation with brain concentrations and pharmacodynamic actions J. Pharmacol. Exp. Ther. 240:1987;516-522.
37. Petersen E. N., Jensen L. H., Drejer J., Honoré T. New perspectives in benzodiazepine receptor pharmacology. Pharmacopsychiatry. 19:1986;4-6.
38. Polc P., Bonetti E. P., Schaffner R., Haefely W. A three state model of the benzodiazepine receptor explains the interaction between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquilizers, β-carbolines, and phenobarbitone. Naunyn-Schmiedeberg's Arch. Pharmacol. 321:1982;260-264.
39. Potier M. C., Prado de Carvalho L., Vanault P., Chapouthier G., Rossier J. Demonstration of the partial agonist profiles of Ro 16-6028 and Ro 17-1812 in mice in vivo. Eur. J. Pharmacol. 156:1988;169-172.
40. A-benzodiazepine receptors produced in transfected cells. Science. 245:1989;1389-1392.
41. A receptor subunit for benzodiazepine pharmacology. Nature. 338:1989;582-584.
42. Schofield P. R., Darlinson M. G., Fujita N., Burt D. R., Stephenson F. A., Rodriguez H., Rhee L. M., Ramachandran J., Reale V., Glecorse T. A., Seeburg P. H., Barnard E. A. Sequence and functional expression of the GABA receptor shows a ligand-gated receptor superfamily. Nature. 328:1987;221-227.
43. Seyfried T. N., Glaser G. H. A review of mouse mutants as genetic models of epilepsy. Epilepsia. 26:1985;143-150.
44. Sieghart W., Eichinger A., Riederer P., Jellinger K. Comparison of benzodiazepine receptor binding in membranes from human or rat brain. Neuropharmacology. 24:1985;751-759.
45. Sieghart W., Karobath M. Molecular heterogeneity of benzodiazepine receptors. Nature. 286:1980;285-287.
46. Squires R. F. Benzodiazepine receptor multiplicity. Neuropharmacology. 27:1983;1443-1450.
47. Stephenson F. A. Understanding the GABA receptor. A chemically gated ion channel Biochem. J. 249:1988;221-227.
48. Tietz E. I., Rosenberg H. C., Chiu T. H. A comparison of the anticonvulsant effects of 1,4- and 1,5-benzodiazepines in amygdala kindled rat and their effects on motor function. Epilepsy Res. 3:1989;31-40.
49. Tricklebank M. D., Honoré T., Iversen S. D., Kemp J. A., Knight A. R., Marshall G. R., Rupniak N. M. J., Singh L., Tye S., Watjen F., Wong E. H. F. The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor. Br. J. Pharmacol. 101:1990;753-761.
50. Villar H. O., Davies M. F., Loew G. H., Maguire P. H. Molecular models for recognition and activation at the benzodiazepine receptor. A review Life Sci. 48:1991;593-602.